Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FUT4 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | C16orf87 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |
mRNA | ABHD14A-ACY1 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | DUSP10 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | CRYL1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
mRNA | KIAA0930 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | LPCAT2 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | RPP25 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | ETV6 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | HSD17B11 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |